Human-Induced Hepatocytes-Derived Extracellular Vesicles Ameliorated Liver Fibrosis in Mice Via Suppression of TGF-β1/Smad Signaling and Activation of Nrf2/HO-1 Signaling
Stem Cells and Development · 2023
DOI: 10.1089/scd.2023.0110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells and Development, 2023. Verfasst von Wenjing Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Liver Diseases, Extracellular Vesicles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Liver fibrosis is a wound-healing response caused by persistent liver injury and often occurs in chronic liver diseases. Effective treatments for liver fibrosis are still pending. Recent studies have revealed that extracellular vesicles (EVs) derived from primary hepatocytes (Hep-EVs) have therapeutic potential for multiple liver diseases. However, Hep-EVs are difficult to manufacture in bulk because of the limited sources of primary hepatocytes. Human-induced hepatocytes (hiHep) are hepatocyte-like cells that can expand in vitro, and their cell culture supernatant is thus an almost unlimited resource for EVs. This study aimed to investigate the potential therapeutic effects of EVs derived from hiHeps. hiHep-EVs inhibited the expression of inflammatory genes and the secretion of inflammation-related cytokines, and suppressed the activation of hepatic stellate cells by inhibiting the transforming growth factor (TGF)-β1/Smad signaling pathway. The anti-inflammatory and antifibrotic effects of hiHep-EVs were similar to those of mesenchymal stem cell-EVs. Furthermore, the administration of hiHep-EVs ameliorated oxidative stress, inflammation, and fibrosis in a CCl 4 -induced liver fibrosis mouse model. The expression of α smooth muscle actin, collagen I, and collagen III was reduced, which may be attributed to the regulation of matrix metalloproteinase (MMP)-9, tissue inhibitor of metalloproteinases (TIMP)-1, and TIMP-2 by hiHep-EVs, and the protein expression of Nrf2, HO-1, and NQO1 was increased. Taken together, our results suggested that hiHep-EVs alleviated liver fibrosis by activating the Nrf2/HO-1 signaling pathway and inhibiting the TGF-β1/Smad signaling pathway. This study revealed the hepatoprotective effect of hiHep-EVs, and provided a new approach to treating liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- University of Chinese Academy of Sciences, Beijing, China.
- School of Pharmacy, Guang Dong Medical University, Dongguan, China.
- Department of Chemical and Environmental Engineering, University of Nottingham Ningbo China, Ningbo, China.
- Carbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
ORCID-Profile: Guoyu Pan
Zitieren
APA
Liu, W., Wu, J., Cao, H., Ma, C., Wu, Z., Tian, Y., Ma, C., Qiu, H., & Pan, G. (2023). Human-Induced Hepatocytes-Derived Extracellular Vesicles Ameliorated Liver Fibrosis in Mice Via Suppression of TGF-β1/Smad Signaling and Activation of Nrf2/HO-1 Signaling. Stem Cells and Development. https://doi.org/10.1089/scd.2023.0110
Vancouver
Liu W, Wu J, Cao H, Ma C, Wu Z, Tian Y, et al. Human-Induced Hepatocytes-Derived Extracellular Vesicles Ameliorated Liver Fibrosis in Mice Via Suppression of TGF-β1/Smad Signaling and Activation of Nrf2/HO-1 Signaling. Stem Cells and Development. 2023. doi:10.1089/scd.2023.0110
BibTeX
@article{Liu2023,
author = {Liu, Wenjing and Wu, Jiajun and Cao, Huiying and Ma, Chen and Wu, Zhitao and Tian, Youxi and Ma, Chenhui and Qiu, Hong and Pan, Guoyu},
title = {Human-Induced Hepatocytes-Derived Extracellular Vesicles Ameliorated Liver Fibrosis in Mice Via Suppression of TGF-β1/Smad Signaling and Activation of Nrf2/HO-1 Signaling},
journal = {Stem Cells and Development},
year = {2023},
doi = {10.1089/scd.2023.0110}
}
EUVIMED